Clinical Trials Arena on MSN19h
Blue Earth’s radioligand therapy achieves high tumour radiation absorption
Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.
Pressure engineering reveals organic–inorganic interaction sites in hybrid perovskites
A Jilin University team has reported a novel strategy using pressure engineering to identify the organic–inorganic ...
eLife3d
Coral anthozoan-specific opsins employ a novel chloride counterion for spectral tuning
This study makes the fundamental discovery of the first natural animal rhodopsin that uses a chloride ion instead of an amino acid side chain as a counterion. Using a combination of biochemical and ...